Healthcare shares are flat in pre-market trade.
Specialty biopharmaceutical company Shire PLC (
) said Friday that it has extended the expiration of its previously
announced tender offer by its subsidiary for ViroPharma (
) until midnight, Eastern Time, on Thursday, January 9, 2014. The
tender offer had previously been scheduled to expire at 6:00 p.m.
ET, on Thursday, December 26, 2013.
As of 6:00 p.m. on December 26, 2013, approximately 76% of
ViroPharma common shares had been validly tendered.
And, Stemcells (
) has filed to sell $100 million worth of stock, warrants and debt
securities and will use the money for general corporate purposes,
STEM is up 5.3% at $1.39 in pre-market trade, with a 52-week
range of $1.16 to $2.16.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.